Brief: Frequency Therapeutics Inc Reports Q3 Loss Per Share Of $0.55

Korro Bio

08/11/2022 21:26

Nov 8 (Reuters) - Frequency Therapeutics Inc  FREQ.O :
    * FREQUENCY THERAPEUTICS PROVIDES BUSINESS UPDATES AND THIRD
QUARTER 2022 FINANCIAL RESULTS
    * FREQUENCY THERAPEUTICS - ENROLLMENT COMPLETED FOR PHASE 2B
STUDY
OF FX-322 FOR TREATMENT OF SENSORINEURAL HEARING LOSS; READOUT
EXPECTED IN Q1 2023
    * QTRLY LOSS PER SHARE $0.55
    * Q3 EARNINGS PER SHARE VIEW $-0.57 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw37Lz8Fa 
Further company coverage:  FREQ.O 
 ((Reuters.Briefs@thomsonreuters.com;))